Overhoff’s gross sales revenue has been steadily increasing each year for the past 3 years (2021:
The need for high-quality tritium monitoring equipment has never been bigger and increases every day. Needed by every nuclear power plant, almost every one of the 17 U.S. national labs plus international labs, and every fusion start-up, big or small in all the developed nations, US Nuclear’s Overhoff tritium monitors are in high demand. Overhoff is in full-gear delivering orders and driving revenue.
US Nuclear’s Overhoff division is the world’s leading tritium monitoring, manufacturer and business is booming. Which is not surprising since Overhoff builds products that are at the same time, more robust, sensitive, dependable, better designed, and available with a much wider range of features and capabilities than competitors.
Tritium, a radioactive isotope of hydrogen, is commonly used in various industrial processes, including nuclear power generation, research, and manufacturing. While tritium plays a crucial role in these applications, its presence requires vigilant monitoring to ensure safety and regulatory compliance.
Overhoff receives both small and large-scale orders for tritium monitoring equipment depending on the scope of the project. An example is the
Overhoff currently has a robust order backlog of more than
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding
CONTACT:
Ph: (818) 883 7043
Email: info@usnuclearcorp.com
http://usnuclearcorp.com
https://overhoff.com/
https://tech-associates.com/
Source:
2024 GlobeNewswire, Inc., source